background
influenza
c
viru
icv
associ
acut
respiratori
ill
yet
icv
remain
recogn
previou
studi
use
cultur
identifi
case
object
develop
sensit
specif
realtim
rtpcr
assay
icv
allow
rapid
accur
detect
clinic
research
set
studi
design
multipl
icv
sequenc
obtain
genbank
analyz
includ
hemagglutininesteras
matrix
nucleoprotein
np
sequenc
primer
probe
design
base
conserv
region
multipl
primerprob
set
test
multipl
icv
strain
result
icv
np
gene
offer
conserv
sequenc
region
primer
probe
base
newer
sequenc
data
offer
enhanc
detect
icv
especi
low
titer
specimen
nptarget
assay
yield
best
perform
capabl
detect
rna
copi
per
reaction
np
assay
detect
multipl
clinic
isol
icv
collect
field
epidemiolog
studi
conduct
peru
conclus
report
new
realtim
rtpcr
assay
icv
high
sensit
specif
realtim
rtpcr
perform
reaction
contain
forward
revers
primer
probe
extract
rna
abi
steponeplu
thermo
fisher
use
agpathid
onestep
rtpcr
kit
thermo
fisher
cycl
condit
http
dx
influenza
c
viru
icv
recogn
caus
acut
respiratori
ill
ari
human
sinc
howev
sinc
icv
difficult
cultur
true
burden
diseas
remain
unclear
seropreval
icv
report
high
year
age
suggest
mani
infect
occur
earli
childhood
recent
rtpcr
studi
suggest
icv
may
commonli
associ
ari
previous
thought
howev
icv
assay
commerci
avail
wide
test
children
sought
develop
new
realtim
rtpcr
assay
icv
base
avail
sequenc
data
use
assay
test
specimen
collect
studi
peruvian
children
ari
publish
np
gene
sequenc
obtain
genbank
align
use
macvector
macvector
sequenc
list
supplement
tabl
primer
probe
design
use
primer
express
appli
biosystem
target
conserv
region
test
previous
publish
icv
realtim
rtpcr
assay
target
np
gene
probe
fam
black
hole
quencher
purifi
hplc
cycl
fluoresc
measur
annealingextens
step
nucleasefre
water
serv
neg
control
experi
primer
probe
target
gene
sequenc
test
plasmid
contain
segment
code
region
cann
assay
test
rna
extract
cultur
cann
c
ann
arbor
ctay
prototyp
icv
strain
sensit
linear
assay
determin
use
rna
runoff
transcript
gener
rna
runoff
transcript
assay
target
gene
segment
clone
pgem
promega
transcrib
vitro
hinciidigest
plasmid
use
rnapol
neb
purifi
quantifi
spectrophotometri
assay
test
multipl
replic
serial
dilut
rna
transcript
specif
assay
determin
test
rna
influenza
virus
b
human
metapneumoviru
mpv
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
parainfluenza
viru
piv
type
adenoviru
adv
coronavirus
mer
assay
test
nasal
swab
ns
specimen
studi
respiratori
infect
andean
peruvian
children
respiraperu
prospect
cohort
studi
design
evalu
epidemiolog
respiratori
virus
ari
among
young
andean
children
fulli
describ
elsewher
briefli
studi
conduct
rural
provinc
san
marco
peruvian
northern
highland
dynam
cohort
children
year
follow
may
septemb
weekli
activ
householdbas
ari
surveil
ari
defin
presenc
cough
fever
ari
consid
sever
aripneumonia
sign
symptom
lower
respiratori
infect
present
includ
tachypnea
wheez
nasal
flare
retract
grunt
stridor
cyanosi
gener
world
health
organ
danger
sign
inabl
drink
lethargi
etc
newborn
studi
household
enrol
children
follow
third
birthday
loss
followup
withdraw
consent
death
end
studi
train
field
worker
visit
home
enrol
child
weekli
collect
inform
respiratori
sign
symptom
preced
week
standard
questionnair
obtain
ns
child
ari
ns
also
obtain
studi
children
asymptomat
period
ns
place
remel
transport
medium
transport
ice
local
research
laboratori
within
h
frozen
rna
extract
thaw
specimen
viral
rna
kit
appli
biosystem
specimen
test
previous
influenza
ab
rsv
mpv
piv
icv
assay
develop
influenza
c
pcr
assay
optim
valid
assay
perform
rna
extract
specimen
previous
use
test
specifi
respiratori
virus
specimen
test
realtim
rtpcr
rnase
p
ensur
rna
integr
exclud
pcr
inhibit
studi
approv
irb
vanderbilt
univers
instituto
de
investigacion
nutricion
clinic
featur
preval
codetect
respiratori
virus
icv
compar
influenza
iav
frequent
detect
influenza
type
parent
studi
use
chisquaredfish
exact
test
categor
variabl
ttest
continu
variabl
analyz
hemagglutininesteras
gene
genbank
substanti
divers
among
gene
highli
conserv
primer
probe
could
identifi
shown
contrast
icv
nucleoprotein
np
matrix
gene
highli
transcrib
well
conserv
among
differ
lineag
viru
publish
fulllength
np
n
n
gene
sequenc
obtain
genbank
align
macvector
design
multipl
primer
probe
combin
two
new
assay
target
new
assay
direct
np
publish
np
assay
test
primer
probe
sequenc
list
tabl
primer
probe
sequenc
minim
mismatch
align
viral
gene
sequenc
shown
assay
target
initi
test
use
serial
dilut
dna
plasmid
templat
assay
detect
dilut
plasmid
dna
compar
threshold
cycl
ct
valu
fig
howev
intens
fluoresc
assay
much
lower
detect
highli
variabl
plasmid
fluoresc
intens
ident
plasmid
fig
assay
target
assay
target
np
test
rna
extract
dilut
cann
arbor
ctaylor
stock
viral
cultur
evalu
ct
lowest
variabl
fluoresc
emiss
intens
compar
assay
also
less
sensit
detect
ctaylor
although
compar
ct
cann
arbor
assay
show
sensit
similar
howev
magnitud
fluoresc
signal
assay
much
lower
remain
assay
shown
therefor
test
rna
icvposit
specimen
previous
collect
nashvil
extract
test
assay
specimen
detect
assay
similar
ct
valu
assay
thu
compar
sensit
shown
therefor
anticip
assay
would
success
detect
divers
strain
icv
determin
whether
assay
could
success
detect
lower
concentr
rna
assay
test
serial
dilut
rna
extract
undilut
ctaylor
stock
cultur
ct
three
assay
similar
fig
assay
superior
assay
thu
test
fig
assay
subsequ
test
serial
dilut
rna
extract
cann
arbor
ctaylor
assay
exhibit
slightli
lower
ct
ctaylor
fig
howev
except
dilut
ctaylor
demonstr
increas
consist
sensit
detect
strain
fig
due
reliabl
sensit
assay
use
decid
character
assay
determin
linear
perform
limit
detect
assay
gener
rna
runoff
transcript
target
gene
segment
assay
demonstr
linear
perform
eight
serial
dilut
fig
limit
detect
assay
rna
copi
per
reaction
ensur
specif
analyz
primer
probe
sequenc
ncbi
blast
detect
genet
sequenc
similar
fig
perform
assay
test
prototyp
icv
strain
plot
cycl
threshold
ct
versu
rna
dilut
ct
vs
rna
dilut
b
vs
rna
dilut
assay
test
dna
plasmid
encod
gene
cann
arbor
ctaylor
c
ct
vs
rna
dilut
vs
rna
dilut
assay
test
rna
ctaylor
tay
e
ct
vs
rna
dilut
f
vs
rna
dilut
assay
test
rna
cann
arbor
aa
c
taylor
tay
g
ct
vs
rna
copi
number
assay
test
serial
dilut
rna
runoff
transcript
error
bar
sem
three
separ
run
respiratori
virus
none
seen
assay
test
triplic
known
influenza
virus
b
mpv
rsv
hrv
piv
adv
coronavirus
mer
icv
neg
control
sampl
neg
except
icv
sampl
shown
total
children
enrol
respiraperu
studi
ari
episod
observ
childyear
risk
nasal
swab
collect
children
ari
test
virus
rtpcr
test
posit
icv
tabl
median
ari
durat
day
iqr
icv
infect
fever
cough
rhinorrhea
occur
commonli
icv
infect
respect
one
icv
infect
classifi
pneumonia
base
presenc
agespecif
tachypnea
monthold
child
none
children
icv
infect
exhibit
nasal
flare
stridor
wheez
ari
ns
test
virus
test
posit
iav
fever
significantli
common
iav
vs
icv
infect
vs
p
decreas
appetit
malais
tabl
codetect
least
one
respiratori
viru
occur
significantli
frequent
icv
iav
p
icv
codetect
one
viru
ari
episod
virus
ari
episod
hrv
virus
frequent
codetect
icv
ari
episod
respect
icv
infect
classifi
pneumonia
associ
codetect
adv
previous
report
detect
influenza
virus
rare
asymptomat
period
cohort
asymptomat
respiratori
sampl
posit
influenza
viru
three
posit
iav
posit
icv
rel
report
burden
clinic
featur
icv
infect
particularli
among
young
children
symptomat
icv
infect
thought
frequent
lack
recognit
icv
infect
seem
attribut
difficulti
isol
pathogen
also
mild
symptom
associ
icv
compar
influenza
type
report
new
realtim
rtpcr
assay
accur
detect
icv
although
rtpcr
assay
icv
previous
describ
usual
develop
base
sequenc
contrast
design
novel
icv
assay
base
avail
sequenc
genbank
includ
sequenc
origin
ctaylor
strain
thu
assay
like
remain
capabl
detect
futur
circul
strain
found
np
gene
highli
conserv
icv
gene
new
assay
abl
detect
divers
strain
icv
high
sensit
specif
use
assay
character
icv
infect
among
young
children
peruvian
and
detect
icv
among
children
ari
studi
compar
previou
studi
outsid
outbreak
set
molecular
diagnost
method
use
set
icv
typic
detect
subject
ari
although
studi
restrict
pediatr
popul
includ
assess
hospit
well
outpati
subject
previou
studi
report
symptom
icv
infect
mild
fever
cough
rhinorrhea
occur
frequent
result
similar
find
children
follow
household
surveil
howev
anoth
studi
japan
respiratori
tract
specimen
collect
symptomat
children
visit
one
four
clinic
three
hospit
specimen
overlap
nationwid
icv
epidem
icv
detect
associ
pneumonia
bronchiol
anoth
studi
hospit
children
japan
report
icv
detect
children
hospit
lower
respiratori
tract
ill
infect
associ
similar
proport
pneumonia
compar
human
metapneumoviru
mpv
infect
studi
other
hospit
children
children
pneumonia
suggest
typic
clinic
symptom
icv
infect
could
character
common
coldlik
ill
complic
lower
respiratori
tract
infect
requir
hospit
may
also
occur
studi
compar
clinic
manifest
among
infect
differ
influenza
type
studi
report
similar
clinic
featur
sever
associ
icv
iav
howev
similar
find
earlier
studi
found
fever
common
durat
fever
longer
among
children
iav
compar
icv
anoth
studi
icv
among
militari
recruit
finland
demonstr
substanti
differ
proport
fever
iav
compar
icv
group
also
found
codetect
virus
occur
frequent
symptomat
icv
infect
influenza
type
although
codetect
associ
sever
symptom
addit
demonstr
icv
detect
rare
among
asymptomat
children
indic
present
viru
like
contribut
pathogenesi
respiratori
ill
studi
sever
import
strength
one
report
children
ari
follow
via
longitudin
commun
householdbas
surveil
captur
rel
milder
spectrum
diseas
report
pediatr
icv
infect
studi
featur
ill
among
children
present
admit
health
care
facil
therefor
find
expand
understand
spectrum
icv
diseas
studi
also
subject
limit
test
publish
primerprob
set
might
perform
well
despit
nucleotid
mismatch
furthermor
silico
analysi
alway
predict
vitro
perform
howev
includ
one
assay
use
studi
icv
epidemiolog
compar
assay
perform
well
though
sequencebas
modif
perform
assay
enhanc
valid
specif
instrument
kit
necessari
molecular
assay
addit
assess
assay
set
would
help
final
icv
frequent
associ
detect
respiratori
virus
ari
episod
clarifi
role
icv
caus
agent
ill
difficult
addit
research
need
topic
summari
develop
new
accur
icv
realtim
rtpcr
assay
base
comparison
multipl
icv
gene
sequenc
assay
exhibit
linear
perform
detect
virus
divers
lineag
time
enhanc
detect
icv
clinic
specimen
demonstr
icv
infect
among
young
peruvian
children
ari
icv
infect
infrequ
associ
lower
respiratori
tract
ill
householdbas
surveil
studi
new
assay
use
futur
epidemiolog
studi
divers
popul
jvw
serv
scientif
advisori
board
quidel
independ
data
monitor
committe
glaxosmithklin
mrg
receiv
grant
fund
medimmun
kme
receiv
research
fund
serv
data
safeti
monitor
board
novarti
cgg
serv
consult
pfizer
merck
cfl
advisor
takeda
vaccin
divis
author
potenti
compet
interest
report
